VORVor Biopharma Inc.
$19.16-43% 1Y
$19.16
$6.8652 weeks$33.40
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +14% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How VOR is trading
Vor Biopharma Inc. is −43% over the past year while the S&P 500 is +18%: 62 points behind the market.
−43%
1-year return · S&P 500 +18%
- vs 200-day average
- +14%
vs 200-day average · a clear uptrend
- RSI (14)
- 36
RSI (14) · neutral
- Below its 52-week high
- 43%
Below its 52-week high
Details›
- Last close2026-10-08
- $19.16
- 1 monthS&P 500 +1.6%
- −18%
- 1 yearS&P 500 +18%
- −43%
- 5 yearsS&P 500 +86%
- −94%
- vs 50-day average$21.90
- −12%
- 52-week high
- $33.40
- 52-week low
- $6.86
- Annualised volatility
- 151%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$27M
| Year | Return |
|---|---|
| 2026 (year to date) | +46% |
| 2025 | −41% |
| 2024 | −51% |
| 2023 | −66% |
| 2022 | −43% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 2 of 5 | −4.0% |
| Feb | 5 | 3 of 5 | +2.0% |
| Mar | 6 | 2 of 6 | −9.3% |
| Apr | 6 | 0 of 6 | −18% |
| May | 6 | 2 of 6 | −22% |
| Jun | 6 | 3 of 6 | +113% |
| Jul | 6 | 2 of 6 | −1.1% |
| Aug | 6 | 3 of 6 | +1.1% |
| Sep | 6 | 2 of 6 | −7.0% |
| Oct | 6 | 4 of 6 | −3.8% |
| Nov | 5 | 1 of 5 | −19% |
| Dec | 5 | 5 of 5 | +31% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.